Evidence map›Paper›PMID 35234095›Full record

ArticleAnnals of medicine2022

Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents.

Paavani S Reddy, Stephanie W Cai, Leonardo Barrera, Kathryn King, Sherif M Badawy

Open access · goldAbstract read
In one paragraph

Article in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Observational
  2. Article
  3. Genome editing strategies for targeted correction of β-globin mutation in sickle cell disease: From bench to bedside.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Treatment of sickle cell disease - options and perspective.American journal of blood research · 2023
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Paavani S ReddyDepartment of Medical Education, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Stephanie W CaiDepartment of Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Leonardo BarreraMary Ann & J. Milburn Smith Child Health Research, Outreach, and Advocacy Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Kathryn KingDivision of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Sherif M BadawyDivision of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.ORCID 0000-0002-4739-265X
Northwestern University · USLurie Children's Hospital · US

Funding

An mHealth Strategy to Improve Medication Adherence in Adolescents with Sickle Cell DiseaseK23HL150232 · NHLBI · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI BADAWY, SHERIF MOHAMED · 2020 to 2024
$842k
NHLBI NIH HHS K23 HL150232
6 · The paper itself

Abstract

backgroundSickle cell disease (SCD) results in severe complications, such as anaemia and pain episodes. Hydroxyurea (HU) is efficacious in SCD, yet adherence remains low.

objectiveTo assess the relationship of HU adherence to health care utilization and patients' characteristics.

methodsThis is a 5-year retrospective chart review. Patients' demographics and medical history were collected from the electronic medical record (EMR). HU adherence was evaluated using foetal haemoglobin "HbF%", mean corpuscular volume "MCV", and absolute neutrophil count "ANC". Age groups included children (<12 years), adolescents (12-17 years), and young adults (≥18 years).

resultsA total of 113 SCD patients on HU were included (median age 14 years, IQR 10-20; 50% female; 88% HbSS). Young adults had significantly higher HU adherence compared to adolescents and children, including higher median HbF% (24.2

conclusionsYoung adults with SCD had significantly higher HU adherence compared to children and adolescents. Patients with lower HU adherence and/or chronic pain had increased health care utilization. Future studies examining barriers to adherence and evaluating interventions to optimize HU adherence in SCD are warranted.KEY MESSAGESYoung adults with SCD had significantly higher HU adherence, as reflected in their laboratory markers, compared to children and adolescents.Patients with higher HU adherence and/or those without chronic pain had lower or less frequent health care utilization.No significant association of HU adherence to patients' sex, socio-economic status and distance from hospital.

Indexed as

Anemia, Sickle CellHydroxyureaAdolescentChildFemaleHospitalizationHumansMaleMedication AdherenceRetrospective StudiesYoung AdultHydroxyureaadherenceadolescents and young adultsAYAchronic paincompliancehaemoglobinopathyhealth care utilizationhydroxycarbamidehydroxyureaSickle cell

Identifiers

PMID35234095
PMCPMC8896206
OpenAlexW4214845530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.